+90 536 878 3636
"Excessive iron absorption, associated with low levels of hepcidin, can lead to severe morbidity and mortality. Conversely, iron anemia due to low levels of iron in the blood affects roughly 1 billion people worldwide.
DRG is very proud and equally pleased to introduce the DRG Hepcidin 25 ELISA, which will help revolutionize future research, diagnosis, and treatment of anemias and iron overload diseases."
Copyright - 2019 MEDİTEK R&D TIBBİ CİHAZ SİSTEMLERİ